349 related articles for article (PubMed ID: 25122789)
1. The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.
O'Donnell CD; Vogel L; Matsuoka Y; Jin H; Subbarao K
J Virol; 2014 Nov; 88(21):12374-84. PubMed ID: 25122789
[TBL] [Abstract][Full Text] [Related]
2. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
[TBL] [Abstract][Full Text] [Related]
3. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.
Campbell PJ; Danzy S; Kyriakis CS; Deymier MJ; Lowen AC; Steel J
J Virol; 2014 Apr; 88(7):3802-14. PubMed ID: 24429367
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.
Chen GL; Lamirande EW; Cheng X; Torres-Velez F; Orandle M; Jin H; Kemble G; Subbarao K
J Virol; 2014 Mar; 88(5):2867-76. PubMed ID: 24371061
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.
Boonnak K; Paskel M; Matsuoka Y; Vogel L; Subbarao K
Vaccine; 2012 Aug; 30(38):5603-10. PubMed ID: 22789506
[TBL] [Abstract][Full Text] [Related]
6. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
[TBL] [Abstract][Full Text] [Related]
7. Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.
Russier M; Yang G; Briard B; Meliopoulos V; Cherry S; Kanneganti TD; Schultz-Cherry S; Vogel P; Russell CJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694942
[TBL] [Abstract][Full Text] [Related]
8. The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A/WSN/33 viruses.
Broadbent AJ; Santos CP; Godbout RA; Subbarao K
J Virol; 2014 Nov; 88(21):12339-47. PubMed ID: 25122786
[TBL] [Abstract][Full Text] [Related]
9. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
[TBL] [Abstract][Full Text] [Related]
10. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
[TBL] [Abstract][Full Text] [Related]
11. Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.
Zhou B; Meliopoulos VA; Wang W; Lin X; Stucker KM; Halpin RA; Stockwell TB; Schultz-Cherry S; Wentworth DE
J Virol; 2016 Oct; 90(19):8454-63. PubMed ID: 27440882
[TBL] [Abstract][Full Text] [Related]
12. Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.
Nogales A; Steel J; Liu WC; Lowen AC; Rodriguez L; Chiem K; Cox A; García-Sastre A; Albrecht RA; Dewhurst S; Martínez-Sobrido L
Microbiol Spectr; 2022 Jun; 10(3):e0007822. PubMed ID: 35583364
[TBL] [Abstract][Full Text] [Related]
13. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
[TBL] [Abstract][Full Text] [Related]
15. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
16. A North American H7N3 Influenza Virus Supports Reassortment with 2009 Pandemic H1N1 and Induces Disease in Mice without Prior Adaptation.
Williams GD; Pinto AK; Doll B; Boon ACM
J Virol; 2016 May; 90(9):4796-4806. PubMed ID: 26937034
[TBL] [Abstract][Full Text] [Related]
17. Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin.
Cline TD; Karlsson EA; Freiden P; Seufzer BJ; Rehg JE; Webby RJ; Schultz-Cherry S
J Virol; 2011 Dec; 85(23):12262-70. PubMed ID: 21917948
[TBL] [Abstract][Full Text] [Related]
18. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
Li X; Gao Y; Ye Z
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
[TBL] [Abstract][Full Text] [Related]
19. Influenza Virus with Increased pH of Hemagglutinin Activation Has Improved Replication in Cell Culture but at the Cost of Infectivity in Human Airway Epithelium.
Singanayagam A; Zambon M; Barclay WS
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189708
[TBL] [Abstract][Full Text] [Related]
20. Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination.
Peng Y; Wang B; Talaat K; Karron R; Powell TJ; Zeng H; Dong D; Luke CJ; McMichael A; Subbarao K; Dong T
Front Immunol; 2015; 6():287. PubMed ID: 26082783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
